Revolutionizing Malignant Brain Cancer Therapy
Localized therapy to improve outcomes for patients
Revolutionizing Malignant Brain Cancer Therapy
Localized therapy to improve outcomes for patients
About Us
Our Mission
Our Expertise
Our Expertise
At Vivo, our mission is to develop novel, targeted therapies to improve the outcome of people fighting critical conditions around the world.
Our Expertise
Our Expertise
Our Expertise
Our dedicated team brings decades of collective experience to the forefront of drug development. The team has successfully navigated the complexities of clinical trials, regulatory approvals and patient-centric research. Our commitment to innovation drives us to explore novel approaches to help accelerate the drug development process wi
Our dedicated team brings decades of collective experience to the forefront of drug development. The team has successfully navigated the complexities of clinical trials, regulatory approvals and patient-centric research. Our commitment to innovation drives us to explore novel approaches to help accelerate the drug development process without compromising scientific rigor. Because patients can't wait.
SI-053
Our Expertise
SI-053
Is a novel hydrogel format of temozolomide that is locally administered at the time of surgery. SI-053 is undergoing investigation to improve efficacy while reducing systemic side effects in a clinical trial with patients fighting glioblastoma (GBM).